• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B细胞抗原受体信号传导的分子剖析(综述)

Molecular dissection of B cell antigen receptor signaling (review).

作者信息

Kurosaki T

机构信息

Department of Molecular Genetics, Institute for Liver Research, Kansai Medical University, Moriguchi 570, Japan.

出版信息

Int J Mol Med. 1998 Mar;1(3):515-27. doi: 10.3892/ijmm.1.3.515.

DOI:10.3892/ijmm.1.3.515
PMID:9852257
Abstract

In B lymphocytes, signaling through the B cell antigen receptor (BCR) contributes to cell fate decisions with different extents of receptor engagement leading to such outcomes as cell death, survival, or proliferation. During the past several years we have seen significant strides in our understanding of the signaling pathways that connect the BCR to the nucleus. Stimulation of the BCR leads to the activation of three types of intracellular protein tyrosine kinases Lyn, Syk, and Btk. Concerted action of these tyrosine kinases leads to the phosphorylation of multiple substrates and to activation of a variety of signaling pathways including phospholipase C-gamma, Ras, and phosphatidylinositol 3-kinase activation. The ability of B lymphocytes to react appropriately to a wide variety of environment stimuli requires a high degree of regulation on these multiple signaling pathways.

摘要

在B淋巴细胞中,通过B细胞抗原受体(BCR)进行的信号传导有助于细胞命运的决定,不同程度的受体结合会导致细胞死亡、存活或增殖等结果。在过去几年中,我们对连接BCR与细胞核的信号通路的理解取得了重大进展。BCR的刺激会导致三种类型的细胞内蛋白酪氨酸激酶Lyn、Syk和Btk的激活。这些酪氨酸激酶的协同作用导致多种底物的磷酸化,并激活包括磷脂酶C-γ、Ras和磷脂酰肌醇3-激酶激活在内的多种信号通路。B淋巴细胞对多种环境刺激做出适当反应的能力需要对这些多种信号通路进行高度调节。

相似文献

1
Molecular dissection of B cell antigen receptor signaling (review).B细胞抗原受体信号传导的分子剖析(综述)
Int J Mol Med. 1998 Mar;1(3):515-27. doi: 10.3892/ijmm.1.3.515.
2
Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.B细胞共受体CD19和CD22对MHC II类信号转导的调控。
J Immunol. 2000 Nov 15;165(10):5588-96. doi: 10.4049/jimmunol.165.10.5588.
3
CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.在B细胞活化时,CD22与蛋白酪氨酸磷酸酶1C、脾酪氨酸激酶和磷脂酶C-γ1相互作用。
J Exp Med. 1996 Feb 1;183(2):547-60. doi: 10.1084/jem.183.2.547.
4
Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.Lyn缺陷型B淋巴细胞中抗原受体信号传导的负调控缺陷。
Curr Biol. 1998 May 7;8(10):545-53. doi: 10.1016/s0960-9822(98)70223-4.
5
Signal transduction via the B-cell antigen receptor: the role of protein tyrosine kinases and protein tyrosine phosphatases.通过B细胞抗原受体的信号转导:蛋白酪氨酸激酶和蛋白酪氨酸磷酸酶的作用
Curr Top Microbiol Immunol. 2000;245(1):1-51. doi: 10.1007/978-3-642-57066-7_1.
6
The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.B细胞受体连接后Lyn和CD19的激活及后续调节作用是相互独立的。
J Immunol. 2002 Dec 15;169(12):6910-8. doi: 10.4049/jimmunol.169.12.6910.
7
CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.B淋巴细胞Ca2+反应的CD19扩增:Lyn隔离在消除负调控中的作用。
J Biol Chem. 2001 Nov 30;276(48):44820-7. doi: 10.1074/jbc.M107559200. Epub 2001 Oct 2.
8
Co-receptors on B lymphocytes.B淋巴细胞上的共受体
Curr Opin Immunol. 1999 Jun;11(3):249-55. doi: 10.1016/s0952-7915(99)80041-7.
9
Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.B细胞抗原受体介导的布鲁顿酪氨酸激酶激活需要CD19 Y484和Y515的磷酸化以及磷脂酰肌醇3激酶的相关激活。
J Immunol. 1999 Apr 15;162(8):4438-46.
10
A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals.双刃剑激酶Lyn:抗原受体介导信号的正负调节因子
J Exp Med. 1998 Apr 20;187(8):1343-8. doi: 10.1084/jem.187.8.1343.

引用本文的文献

1
Characterizing the structure-activity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase.表征天然产物丹参酮的构效关系,揭示了它们抑制脾酪氨酸激酶的作用模式。
RSC Adv. 2021 Jan 14;11(4):2453-2461. doi: 10.1039/d0ra08769f. eCollection 2021 Jan 6.
2
Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib.前 B 细胞急性淋巴细胞白血病细胞系对依鲁替尼的 SYK 抑制作用的反应存在差异。
Int J Mol Sci. 2021 Jan 8;22(2):592. doi: 10.3390/ijms22020592.
3
RasGRP3 in peripheral blood mononuclear cells is associated with disease activity and implicated in the development of systemic lupus erythematosus.
外周血单核细胞中的RasGRP3与疾病活动相关,并参与系统性红斑狼疮的发病过程。
Am J Transl Res. 2019 Mar 15;11(3):1800-1809. eCollection 2019.
4
Ibrutinib: from bench side to clinical implications.依鲁替尼:从实验室到临床应用
Med Oncol. 2015 Sep;32(9):225. doi: 10.1007/s12032-015-0669-9. Epub 2015 Jul 30.
5
Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth.异常组成型Src 激酶活性促进 B 淋巴瘤的存活和生长。
Mol Cancer. 2009 Dec 31;8:132. doi: 10.1186/1476-4598-8-132.
6
Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.Fc受体样5通过募集SHP-1酪氨酸磷酸酶抑制B细胞活化。
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9770-5. doi: 10.1073/pnas.0703354104. Epub 2007 May 23.
7
Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis.抑制B细胞受体诱导的细胞凋亡需要蛋白磷酸酶亚基G5PR。
J Exp Med. 2005 Sep 5;202(5):707-19. doi: 10.1084/jem.20050637. Epub 2005 Aug 29.
8
Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.慢性淋巴细胞白血病B细胞含有异常的Lyn酪氨酸激酶,这可能是导致凋亡缺陷的一个因素。
J Clin Invest. 2005 Feb;115(2):369-78. doi: 10.1172/JCI22094.
9
The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo.LMP2A免疫受体酪氨酸激活基序对于在体内为B细胞提供发育和存活信号至关重要。
J Virol. 2000 Oct;74(19):9115-24. doi: 10.1128/jvi.74.19.9115-9124.2000.
10
Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling.组胺H1受体信号增强抗原受体介导的反应。
J Exp Med. 1999 Feb 15;189(4):673-82. doi: 10.1084/jem.189.4.673.